Jazz Pharmaceuticals Plc

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
HZNPHorizon Therapeutics Plc 0.00%78.915.6%$205.00m
VRXValeant Pharmaceuticals International, Inc. -0.64%26.2414.1%$154.40m
CTLTCatalent, Inc. -0.26%115.002.1%$113.43m
BHCBausch Health Cos., Inc. -0.64%26.240.0%$90.35m
JAZZJazz Pharmaceuticals Plc 0.00%165.812.4%$87.34m
UTHRUnited Therapeutics Corp. 0.00%167.2614.1%$64.76m
SAGESAGE Therapeutics, Inc. 0.90%97.637.6%$58.81m
ACSTAcasti Pharma, Inc. 2.38%0.650.2%$54.21m
GWPHGW Pharmaceuticals Plc 1.00%139.216.1%$48.88m
AMRNAmarin Corp. Plc 0.33%6.151.5%$47.65m
PRGOPerrigo Co. Plc 0.16%44.726.8%$47.42m
ISRIsoRay, Inc. 6.84%2.032.5%$46.22m
ICLRICON plc 0.00%210.664.2%$42.89m
PCRXPacira Biosciences, Inc. 0.00%77.1610.0%$38.41m
ENDPEndo International Plc 0.69%7.278.7%$38.32m

Company Profile

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.